71![CAREWare Medications Regimen Builder Regimen builder p. 1 CAREWare Medications Regimen Builder Regimen builder p. 1](https://www.pdfsearch.io/img/3c6a2ad3565fc23bf52f218f3c761ce4.jpg) | Add to Reading ListSource URL: hab.hrsa.govLanguage: English - Date: 2014-11-19 01:30:59
|
---|
72![Limitation of Use: Erbitux is not indicated for treatment of K-Ras mutationpositive colorectal cancer. (5.8, [removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Limitation of Use: Erbitux is not indicated for treatment of K-Ras mutationpositive colorectal cancer. (5.8, [removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use](https://www.pdfsearch.io/img/a12425b4e920d88a51edb7385da76afe.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-07-10 09:31:40
|
---|
73![VIEWPOINT www.nature.com/clinicalpractice/onc The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens VIEWPOINT www.nature.com/clinicalpractice/onc The Norton–Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens](https://www.pdfsearch.io/img/f0ca1fdd4a35f56047b6f1222ac03f91.jpg) | Add to Reading ListSource URL: linus.nci.nih.govLanguage: English - Date: 2013-03-12 10:01:33
|
---|
74![New York State Poison Centers The NY State Poison Centers[removed] New York State Poison Centers The NY State Poison Centers[removed]](https://www.pdfsearch.io/img/1d7b8ccddb54e83602bd7cfa554ca108.jpg) | Add to Reading ListSource URL: www.upstate.eduLanguage: English - Date: 2011-06-28 10:31:12
|
---|
75![New York A Quarterly Publication • Vol. XV No. 1 State Poison Centers The New York State Poison Centers[removed] New York A Quarterly Publication • Vol. XV No. 1 State Poison Centers The New York State Poison Centers[removed]](https://www.pdfsearch.io/img/1b4e585680a7a749a9a2010961d810d9.jpg) | Add to Reading ListSource URL: www.upstate.eduLanguage: English - Date: 2011-06-28 10:30:30
|
---|
76![Doxorubicin Hydrochloride Injection, USP HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Doxorubicin Hydrochloride Injection, USP Doxorubicin Hydrochloride Injection, USP HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Doxorubicin Hydrochloride Injection, USP](https://www.pdfsearch.io/img/8e6d28c8a96a8a1aa577556007074975.jpg) | Add to Reading ListSource URL: www.sagentpharma.comLanguage: English - Date: 2014-09-26 12:31:09
|
---|
77![CATALOG DOXORUBICIN Differentiated Packaging on Vials and Cartons Labels are DistinctIV CATALOG DOXORUBICIN Differentiated Packaging on Vials and Cartons Labels are DistinctIV](https://www.pdfsearch.io/img/9a15f8ddf0f5372dad63346423866780.jpg) | Add to Reading ListSource URL: www.sagentpharma.comLanguage: English - Date: 2014-09-26 12:31:06
|
---|
78![Cancer Advances NEWS FROM THE 2004 ASCO ANNUAL MEETING BRAIN CANCER Adding Chemotherapy to Radiation Therapy Cancer Advances NEWS FROM THE 2004 ASCO ANNUAL MEETING BRAIN CANCER Adding Chemotherapy to Radiation Therapy](https://www.pdfsearch.io/img/d8b82cc8b62dbed0049f6093b93edf11.jpg) | Add to Reading ListSource URL: www.cancer.netLanguage: English - Date: 2012-07-02 11:14:33
|
---|
79![THE UNIVERSITY OF GEORGIA® College of Veterinary Medicine Clinical Research Program — Clinical Trials Title: Efficacy of Rabacfosadine (previously known as VDC[removed]in dogs with lymphoma Investigator: THE UNIVERSITY OF GEORGIA® College of Veterinary Medicine Clinical Research Program — Clinical Trials Title: Efficacy of Rabacfosadine (previously known as VDC[removed]in dogs with lymphoma Investigator:](https://www.pdfsearch.io/img/a9fb0118b9e6b6a57d0ce0813e05c2db.jpg) | Add to Reading ListSource URL: www.vet.uga.eduLanguage: English - Date: 2014-05-09 13:30:27
|
---|
80![Title: Evaluation of the efficacy and safety of an immunotherapeutic for the extension of postchemotherapeutic remission times in dogs diagnosed with large B-cell Lymphoma. Investigator: Corey Saba, DVM, DACVIM (Oncology Title: Evaluation of the efficacy and safety of an immunotherapeutic for the extension of postchemotherapeutic remission times in dogs diagnosed with large B-cell Lymphoma. Investigator: Corey Saba, DVM, DACVIM (Oncology](https://www.pdfsearch.io/img/c4c8bea8811b7b241607408598281f9f.jpg) | Add to Reading ListSource URL: vet.uga.eduLanguage: English - Date: 2014-04-22 16:02:41
|
---|